Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.

Rall CJ, Yan YX, Graeme-Cook F, Beauchamp R, Yandell DW, Povoski SP, Rustgi AK.

Pancreas. 1996 Jan;12(1):10-7.

PMID:
8927612
3.

Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.

Urban T, Ricci S, Grange JD, Lacave R, Boudghene F, Breittmayer F, Languille O, Roland J, Bernaudin JF.

J Natl Cancer Inst. 1993 Dec 15;85(24):2008-12.

PMID:
7902444
4.

Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.

Yamada H, Sakamoto H, Taira M, Nishimura S, Shimosato Y, Terada M, Sugimura T.

Jpn J Cancer Res. 1986 Apr;77(4):370-5.

PMID:
3009377
6.

Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.

Itabashi T, Maesawa C, Uchiyama M, Higuchi T, Masuda T.

Int J Oncol. 2004 Mar;24(3):687-96.

PMID:
14767554
7.
8.

Structure and expression of oncogenes in surgical specimens of human breast carcinomas.

Biunno I, Pozzi MR, Pierotti MA, Pilotti S, Cattoretti G, Della Porta G.

Br J Cancer. 1988 May;57(5):464-8.

9.

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M.

Cell. 1988 May 20;53(4):549-54.

PMID:
2453289
10.

Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.

Abbruzzese JL, Evans DB, Raijman I, Larry L, King T, Leach SD, Frazier ML.

Anticancer Res. 1997 Mar-Apr;17(2A):795-801.

PMID:
9137410
11.

Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene.

Gressani KM, Rollins LA, Leone-Kabler S, Cline JM, Miller MS.

Carcinogenesis. 1998 Jun;19(6):1045-52.

12.

p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.

Weyrer K, Feichtinger H, Haun M, Weiss G, Ofner D, Weger AR, Umlauft F, Grünewald K.

Lab Invest. 1996 Jan;74(1):279-89.

PMID:
8569192
13.

K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL.

Am J Pathol. 1993 Aug;143(2):545-54. Review.

15.

Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse.

You M, Candrian U, Maronpot RR, Stoner GD, Anderson MW.

Proc Natl Acad Sci U S A. 1989 May;86(9):3070-4.

16.

Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants.

Meyers FJ, Gumerlock PH, Kokoris SP, deVere White RW, McCormick F.

Cancer. 1989 Jun 1;63(11):2177-81.

17.

Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.

Jiang W, Kahn SM, Guillem JG, Lu SH, Weinstein IB.

Oncogene. 1989 Jul;4(7):923-8.

PMID:
2666911
18.

A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene.

Bos JL, Verlaan-de Vries M, Marshall CJ, Veeneman GH, van Boom JH, van der Eb AJ.

Nucleic Acids Res. 1986 Feb 11;14(3):1209-17.

19.

Activation of a human c-K-ras oncogene.

Yamamoto F, Perucho M.

Nucleic Acids Res. 1984 Dec 11;12(23):8873-85.

20.

Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester.

Jackson PE, Hall CN, Badawi AF, O'Connor PJ, Cooper DP, Povey AC.

Mol Carcinog. 1996 May;16(1):12-9.

PMID:
8634090
Items per page

Supplemental Content

Write to the Help Desk